Feb 4, 2026 08:00AM Izotropic Closes Non-Brokered Private Placement and Announces Debt Settlement

Jan 28, 2026 08:02AM Izotropic announces $300,000 private placement for working capital

Jan 28, 2026 08:00AM Izotropic Provides Corporate Update & Announces Non-Brokered Private Placement

Dec 31, 2025 04:31PM Izotropic Announces AGM Results

Nov 12, 2025 08:00AM Izotropic Launches Podcast Episode #2: AI and the Future of Breast Imaging: How Izotropic is Leading the Innovation

Oct 28, 2025 08:00AM Izotropic Launches "Breast Imaging News" Page on BreastCT.com

Oct 23, 2025 08:00AM Izotropic CEO Interview: IzoView Differentiators, Regulatory Plans, and Outlook

Oct 21, 2025 02:32PM CEO.CA's Inside the Boardroom: This Breast Cancer Tech by Izotropic Targets 50% of Women Currently Underserved

Sep 19, 2025 08:02AM Izotropic raises $375,000 in private placement, hires marketing firms

Sep 19, 2025 08:00AM Izotropic Closes Non-Brokered Private Placement and Engages Awareness Consultants

Sep 10, 2025 01:24PM Izotropic Gains Visibility as AI Market Broadens Beyond Tech

Aug 26, 2025 08:02AM Izotropic announces private placement to raise up to $300K

Aug 26, 2025 08:00AM Izotropic Announces Non-Brokered Private Placement & Extends Warrants

Aug 12, 2025 08:00AM Izotropic Introduces New Corporate Website & Brand Identity

Jul 15, 2025 08:00AM Izotropic Prepares New Platforms to Educate and Engage

Jun 13, 2025 08:00AM Izotropic Provides Marketing Update

Jun 10, 2025 08:00AM Izotropic Revises License Agreement with The Regents of the University of California

May 16, 2025 10:36PM Izotropic's U.S. FDA Regulatory Pathway Greenlit, Company Provides Corporate Update

Apr 2, 2025 03:30PM Izotropic Engages International Communications Consultant, Grants Incentive Stock Options & RSUs to Key Personnel, Amends Promissory Note with Primary Lender

Mar 25, 2025 08:00AM Izotropic Completes Pre-Submission Meeting with FDA for Breast Cancer Screening Indication

Mar 10, 2025 08:00AM Izotropic to Present at Investor Conference March 13th

Feb 19, 2025 08:00AM FDA Sets Meeting Date with Izotropic

Feb 14, 2025 08:00AM Izotropic Closes Non-Brokered Private Placement

Feb 7, 2025 09:00AM Izotropic Announces Non-Brokered Private Placement

Feb 5, 2025 08:31PM Izotropic Reschedules Investor Conference Presentation to March 13th

Feb 3, 2025 08:00AM Izotropic to Present at Investor Conference February 6th

Jan 29, 2025 08:00AM Izotropic Announces Timelines and Milestones to IzoView Product Launch

Jan 17, 2025 08:00AM Izotropic Featured in Announcement of Research and Markets' U.S. Breast Cancer Analysis and Forecast

Jan 15, 2025 08:00AM Izotropic Announces Team Leading Clinical Study Design and FDA Regulatory Submissions

Jan 9, 2025 08:00AM Izotropic Files Pre-Submission with U.S. FDA for Breast Cancer Screening

Dec 4, 2024 02:43PM Izotropic Provides Update on Annual General Meeting Materials and Voting Procedures

Jun 14, 2024 09:00AM Izotropic Corporation Announces Closing of First Tranche of Non-Brokered Private Placement